Literature DB >> 23341378

Positioning of a suburethral sling at the bladder neck is associated with a higher recurrence rate of stress urinary incontinence.

Yuan-Hong Jiang1, Chung-Cheng Wang, Fei-Chi Chuang, Qian-Sheng Ke, Hann-Chorng Kuo.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the relationship between the suburethral sling position and the outcome of anti-incontinence surgery.
METHODS: From 1998 to 2010, the medical records of 153 consecutive women with stress urinary incontinence undergoing the pubovaginal sling procedure were retrospectively reviewed. All patients received preoperative and postoperative transrectal sonography of the bladder and urethra, and the suburethral sling position was used to compare the postoperative continence status and lower urinary tract symptoms.
RESULTS: The mean patient age ± SD was 60.7 ± 10.6 years (range, 34-85 years), and the mean follow-up was 66.3 ± 42.1 months (range, 6-149 months). The slings were located at the bladder neck in 18 patients (11.8%), proximal urethra in 81 (52.9%), middle urethra in 45 (29.4%), and distal urethra in 9 (5.9%). The overall rate of recurrent stress urinary incontinence was 24.2% (37 patients). Among the 153 patients, there was a significantly higher stress urinary incontinence recurrence rate in the bladder neck group (bladder neck, 50.0%; proximal urethra, 18.5%; middle urethra, 22.2%; and distal urethra, 33.3%; P = .037). De novo urge and voiding symptoms occurred in 19.0% and 20.3% of overall patients, respectively. There was no significant difference in either de novo urge or voiding symptoms among groups.
CONCLUSIONS: Positioning of the suburethral sling at the bladder neck appears to be associated with a higher stress urinary incontinence recurrence rate. Patients with slings located at the proximal and middle urethra had the best postsurgical continence rates. The suburethral sling position had no direct association with de novo urge or voiding symptoms.

Entities:  

Mesh:

Year:  2013        PMID: 23341378     DOI: 10.7863/jum.2013.32.2.239

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  7 in total

1.  Using clinical estimate or catheter measurement of urethral mid-point result in similar retropubic mid-urethral sling position: a randomized trial.

Authors:  H C Barnes; A Akl; S K Taege; C Brincat; L Brubaker; E R Mueller
Journal:  Int Urogynecol J       Date:  2022-03-30       Impact factor: 2.894

2.  Transversal incision of the vagina favors the remaining of the tape in the middle-third urethra compared to longitudinal incision during transobturator sling procedures for stress urinary incontinence.

Authors:  L Pirtea; I Sas; Razvan Ilina; D Grigoraș; O Mazilu
Journal:  BMC Surg       Date:  2015-07-17       Impact factor: 2.102

3.  Ultrasound imaging in urogynecology - state of the art 2016.

Authors:  Michał Bogusiewicz
Journal:  Prz Menopauzalny       Date:  2016-11-15

4.  Demographic risk factors for mid-urethral sling failure. Do they really matter?

Authors:  Wojciech Majkusiak; Andrzej Pomian; Edyta Horosz; Aneta Zwierzchowska; Paweł Tomasik; Wojciech Lisik; Ewa Barcz
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

5.  Sonographic sling position and cure rate 10-years after TVT- O procedure.

Authors:  Ayman Tamma; Vesna Bjelic-Radisic; Susanne Hölbfer; Gerda Trutnovsky; Karl Tamussino; Thomas Aigmüller; Daniela Ulrich
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

6.  Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placement.

Authors:  Michał Bogusiewicz; Marta Monist; Krzysztof Gałczyński; Magdalena Woźniak; Andrzej P Wieczorek; Tomasz Rechberger
Journal:  World J Urol       Date:  2014-02-17       Impact factor: 4.226

7.  Tomographic Ultrasound Imaging to Control the Placement of Tension-Free Transobturator Tape in Female Urinary Stress Incontinence.

Authors:  Charlotte M Gräf; Tomas Kupec; Elmar Stickeler; Tamme W Goecke; Ivo Meinhold-Heerlein; Laila Najjari
Journal:  Biomed Res Int       Date:  2016-08-16       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.